These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
233 related articles for article (PubMed ID: 23834173)
1. Targeting proteasomal pathways by dietary curcumin for cancer prevention and treatment. Hasima N; Aggarwal BB Curr Med Chem; 2014; 21(14):1583-94. PubMed ID: 23834173 [TBL] [Abstract][Full Text] [Related]
2. Curcumin inhibits the proteasome activity in human colon cancer cells in vitro and in vivo. Milacic V; Banerjee S; Landis-Piwowar KR; Sarkar FH; Majumdar AP; Dou QP Cancer Res; 2008 Sep; 68(18):7283-92. PubMed ID: 18794115 [TBL] [Abstract][Full Text] [Related]
3. Dysregulation of the ubiquitin-proteasome system by curcumin suppresses coxsackievirus B3 replication. Si X; Wang Y; Wong J; Zhang J; McManus BM; Luo H J Virol; 2007 Apr; 81(7):3142-50. PubMed ID: 17229707 [TBL] [Abstract][Full Text] [Related]
4. Ancient drug curcumin impedes 26S proteasome activity by direct inhibition of dual-specificity tyrosine-regulated kinase 2. Banerjee S; Ji C; Mayfield JE; Goel A; Xiao J; Dixon JE; Guo X Proc Natl Acad Sci U S A; 2018 Aug; 115(32):8155-8160. PubMed ID: 29987021 [TBL] [Abstract][Full Text] [Related]
5. Curcumin induces stress response, neurite outgrowth and prevent NF-kappaB activation by inhibiting the proteasome function. Dikshit P; Goswami A; Mishra A; Chatterjee M; Jana NR Neurotox Res; 2006 Jan; 9(1):29-37. PubMed ID: 16464750 [TBL] [Abstract][Full Text] [Related]
6. Deubiquitinase inhibition of 19S regulatory particles by 4-arylidene curcumin analog AC17 causes NF-κB inhibition and p53 reactivation in human lung cancer cells. Zhou B; Zuo Y; Li B; Wang H; Liu H; Wang X; Qiu X; Hu Y; Wen S; Du J; Bu X Mol Cancer Ther; 2013 Aug; 12(8):1381-92. PubMed ID: 23696216 [TBL] [Abstract][Full Text] [Related]
7. Redox-regulated pathway of tyrosine phosphorylation underlies NF-κB induction by an atypical pathway independent of the 26S proteasome. Cullen S; Ponnappan S; Ponnappan U Biomolecules; 2015 Feb; 5(1):95-112. PubMed ID: 25671697 [TBL] [Abstract][Full Text] [Related]
8. Identification of 4-arylidene curcumin analogues as novel proteasome inhibitors for potential anticancer agents targeting 19S regulatory particle associated deubiquitinase. Yue X; Zuo Y; Ke H; Luo J; Lou L; Qin W; Wang Y; Liu Z; Chen D; Sun H; Zheng W; Zhu C; Wang R; Wen G; Du J; Zhou B; Bu X Biochem Pharmacol; 2017 Aug; 137():29-50. PubMed ID: 28476333 [TBL] [Abstract][Full Text] [Related]
9. The human immunodeficiency virus (HIV)-1 protease inhibitor saquinavir inhibits proteasome function and causes apoptosis and radiosensitization in non-HIV-associated human cancer cells. Pajonk F; Himmelsbach J; Riess K; Sommer A; McBride WH Cancer Res; 2002 Sep; 62(18):5230-5. PubMed ID: 12234989 [TBL] [Abstract][Full Text] [Related]
10. Curcumin induces the degradation of cyclin E expression through ubiquitin-dependent pathway and up-regulates cyclin-dependent kinase inhibitors p21 and p27 in multiple human tumor cell lines. Aggarwal BB; Banerjee S; Bharadwaj U; Sung B; Shishodia S; Sethi G Biochem Pharmacol; 2007 Apr; 73(7):1024-32. PubMed ID: 17240359 [TBL] [Abstract][Full Text] [Related]
11. Prostate carcinoma cell death resulting from inhibition of proteasome activity is independent of functional Bcl-2 and p53. Herrmann JL; Briones F; Brisbay S; Logothetis CJ; McDonnell TJ Oncogene; 1998 Dec; 17(22):2889-99. PubMed ID: 9879995 [TBL] [Abstract][Full Text] [Related]
12. The ubiquitin- and proteasome-dependent degradation of COX-2 is regulated by the COP9 signalosome and differentially influenced by coxibs. Neuss H; Huang X; Hetfeld BK; Deva R; Henklein P; Nigam S; Mall JW; Schwenk W; Dubiel W J Mol Med (Berl); 2007 Sep; 85(9):961-70. PubMed ID: 17429597 [TBL] [Abstract][Full Text] [Related]
13. COP9 signalosome-specific phosphorylation targets p53 to degradation by the ubiquitin system. Bech-Otschir D; Kraft R; Huang X; Henklein P; Kapelari B; Pollmann C; Dubiel W EMBO J; 2001 Apr; 20(7):1630-9. PubMed ID: 11285227 [TBL] [Abstract][Full Text] [Related]
14. The role of the ubiquitin proteasome system in lymphoma. Suh KS; Tanaka T; Sarojini S; Nightingale G; Gharbaran R; Pecora A; Goy A Crit Rev Oncol Hematol; 2013 Sep; 87(3):306-22. PubMed ID: 23541070 [TBL] [Abstract][Full Text] [Related]
15. The nuclear ubiquitin-proteasome system: visualization of proteasomes, protein aggregates, and proteolysis in the cell nucleus. von Mikecz A; Chen M; Rockel T; Scharf A Methods Mol Biol; 2008; 463():191-202. PubMed ID: 18951170 [TBL] [Abstract][Full Text] [Related]
17. When hypoxia signalling meets the ubiquitin-proteasomal pathway, new targets for cancer therapy. Brahimi-Horn C; Pouysségur J Crit Rev Oncol Hematol; 2005 Feb; 53(2):115-23. PubMed ID: 15661562 [TBL] [Abstract][Full Text] [Related]
18. Curcumin (diferuloylmethane) down-regulates expression of cell proliferation and antiapoptotic and metastatic gene products through suppression of IkappaBalpha kinase and Akt activation. Aggarwal S; Ichikawa H; Takada Y; Sandur SK; Shishodia S; Aggarwal BB Mol Pharmacol; 2006 Jan; 69(1):195-206. PubMed ID: 16219905 [TBL] [Abstract][Full Text] [Related]
19. Akt is upstream and MAPKs are downstream of NF-κB in paclitaxel-induced survival signaling events, which are down-regulated by curcumin contributing to their synergism. Bava SV; Sreekanth CN; Thulasidasan AK; Anto NP; Cheriyan VT; Puliyappadamba VT; Menon SG; Ravichandran SD; Anto RJ Int J Biochem Cell Biol; 2011 Mar; 43(3):331-41. PubMed ID: 20883815 [TBL] [Abstract][Full Text] [Related]
20. Probing the anticancer mechanism of prospective herbal drug Withaferin A on mammals: a case study on human and bovine proteasomes. Grover A; Shandilya A; Bisaria VS; Sundar D BMC Genomics; 2010 Dec; 11 Suppl 4(Suppl 4):S15. PubMed ID: 21143798 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]